R&G PharmaStudies (301333.SZ) intends to reduce its shareholding by no more than 1.9193 million shares.
Notice from Noter Technology (301333.SZ): Shareholders Ningbo Kangyunfu Equity Investment Co., Ltd., Ningbo Ruiguang Entrepreneurship Investment Partnership (Limited Partnership), and Ningbo Ruiming Equity Investment Co., Ltd. plan to reduce their holdings in the company, with a total planned reduction of no more than 1.9193 million shares.
R&G PharmaStudies (301333.SZ) announced that the company's shareholders Ningbo Kangyunfu Equity Investment Co., Ltd., Ningbo Ruiguang Entrepreneurship Investment Partnership Enterprise (Limited Partnership), and Ningbo Ruiming Equity Investment Co., Ltd. plan to reduce their holdings of the company's shares, with a total planned reduction of no more than 1.9193 million shares.
Related Articles
GUSHENGTANG (02273) intends to acquire 70% equity of Jinan Xinyang, Jinan Yunshengtang, and Jinan Licheng Yunshengtang.
ST Holdings (08305) received an additional 960,000 shares from its major shareholder, Xu Changcheng.
Huatai (06886): "25 Huatai G5" will pay interest on March 6th.
GUSHENGTANG (02273) intends to acquire 70% equity of Jinan Xinyang, Jinan Yunshengtang, and Jinan Licheng Yunshengtang.
ST Holdings (08305) received an additional 960,000 shares from its major shareholder, Xu Changcheng.
Huatai (06886): "25 Huatai G5" will pay interest on March 6th.
RECOMMEND
